This study is not yet accepting patients

Yoga to Improve Disparities in Cancer Survivorship

a study on Survivorship Cancer, General Neoplasms

Summary

Eligibility
for people ages 18 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCSF
Dates
study started
study ends around
Principal Investigator
by Sorbarikor Piawah, MD, MPH (ucsf)
Headshot of Sorbarikor Piawah
Sorbarikor Piawah

Description

Summary

This clinical trial tests the impact of a racially concordant trainer led yoga program on quality of life and symptom burden in Black and/or African American cancer survivors. Black individuals in the United States are more affected by cancer, despite modern advances. Cancer treatments can impact physical and mental health and overall quality of life and Black individuals report worse physical function and quality of life and less access to culturally appropriate support services. Yoga has been shown to have a positive impact on cancer and cancer treatment related symptoms and quality of life, however, a one size fits all approach has not been shown to be effective in diverse populations. A trainer that shares the same racial or ethnic background as the participant (racially concordant) may have a positive impact on communication, trust, and may improve accessibility and participation. Participating in a yoga program led by a racially concordant trainer may improve quality of life and symptom burden in Black and/or African American cancer survivors.

Details

PRIMARY OBJECTIVE:

  1. Determine the feasibility and acceptability of a yoga intervention among Black individuals with cancer.

SECONDARY OBJECTIVES:

  1. To estimate the effect of the intervention on health-related quality of life.

II. To estimate the effect of the intervention on symptom burden. III. To determine the safety of the intervention.

OUTLINE:

Participants engage in racially concordant trainer led yoga sessions over 60 minutes once weekly (QW) on weeks 1-4 then participate in self-practice video led yoga sessions over 10-15 minutes on weeks 5-8.

After completion of study intervention, patients are followed up at 3 months.

Keywords

Survivorship, Cancer, Cultural support services, Neoplasms, Yoga

Eligibility

You can join if…

Open to people ages 18 years and up

  1. Age >=18 years.
  2. Able to understand study procedures and to comply with them for the entire length of the study.
  3. Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
  4. Diagnosed with any malignancy and/or received any cancer directed therapy within 5 years of enrollment.
  5. Be able to speak, read and write in English.
  6. Self-identify as Black or African American race.
  7. Reside in California.

You CAN'T join if...

  1. Contraindication to any study-related procedure or assessment.
    1. Participants complete the PAR-Q at screening to ensure that they are physically well enough to enroll in the study. If they report any conditions that may be contraindications to physical activity, physician clearance will be required prior to enrollment.
  2. Planned major surgery during the study period.
  3. Any major injuries that limit physical activity.
  4. Plans to receive any form of further cancer therapy during the study period (exception: individuals with breast or prostate cancer are allowed to be on hormone therapy on the study).

Location

  • University of California, San Francisco
    San Francisco 5391959 California 5332921 94143 United States

Lead Scientist at University of California Health

  • Sorbarikor Piawah, MD, MPH (ucsf)
    Dr. Sorbarikor Piawah is a gastrointestinal oncologist with a particular interest in colorectal cancer. She also treats patients with sarcoma, a group of rare cancers that affect the bones and connective tissues. Piawah has a background in public health research, particularly in health care disparities among racial and ethnic minorities and low-income patients with cancer.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT07165600
Study Type
Interventional
Participants
Expecting 50 study participants
Last Updated